Docosanoyl Ethanolamide – 50 mg

Brand:
Cayman
CAS:
94109-05-4
Storage:
-20
UN-No:
Non-Hazardous - /

The endocannabinoids present a rich system of central cannabinoid (CB1), peripheral cannabinoid (CB2), and non-CB receptor-mediated pharmacology that has stimulated research in many fields including memory, weight loss and appetite, neurodegeneration, tumor surveillance, analgesia, and inflammation.{7912,7991} Docosanoyl ethanolamide is a saturated N-acylethanolamide. Non-cannabinoid receptor-mediated pharmacology of the saturated ethanolamides is still being elucidated.{10785} Other studies indicate they may have a role in the functioning of ion channels.{13759}  

 

Available on backorder

SKU: 10005823 - 50 mg Category:

Description

A saturated N-acylethanolamide whose non-CB receptor-mediated pharmacology is still being elucidated; may have a role in the functioning of ion channels


Formal name: N-(2-hydroxyethyl)-docosanamide

Synonyms: 

Molecular weight: 383.7

CAS: 94109-05-4

Purity: ≥98%

Formulation: A crystalline solid


Product Type|Biochemicals|Lipids|Docosanoids||Product Type|Biochemicals|Lipids|Fatty Amides||Research Area|Lipid Biochemistry|Endocannabinoid/Endocannabinoid-like||Research Area|Neuroscience|Cannabinoid Research|Endocannabinoids